Fred Alger Management LLC Sells 21,916 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Fred Alger Management LLC lowered its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 12.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 150,342 shares of the company's stock after selling 21,916 shares during the period. Fred Alger Management LLC owned 1.00% of U.S. Physical Therapy worth $13,337,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Wells Fargo & Company MN boosted its holdings in U.S. Physical Therapy by 2.2% in the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock valued at $10,021,000 after acquiring an additional 2,465 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 37.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock valued at $409,000 after buying an additional 1,254 shares in the last quarter. Copeland Capital Management LLC boosted its holdings in shares of U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after buying an additional 72,715 shares in the last quarter. Proficio Capital Partners LLC bought a new stake in shares of U.S. Physical Therapy during the 4th quarter valued at $3,526,000. Finally, Bridge City Capital LLC boosted its holdings in shares of U.S. Physical Therapy by 7.0% during the 4th quarter. Bridge City Capital LLC now owns 64,947 shares of the company's stock valued at $5,761,000 after buying an additional 4,235 shares in the last quarter.

U.S. Physical Therapy Stock Up 3.9%

U.S. Physical Therapy stock traded up $2.77 during mid-day trading on Friday, reaching $73.68. The stock had a trading volume of 148,017 shares, compared to its average volume of 109,569. The company has a market capitalization of $1.12 billion, a price-to-earnings ratio of 78.38, a PEG ratio of 3.54 and a beta of 1.44. The company has a 50-day moving average price of $72.14 and a two-hundred day moving average price of $83.69. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $108.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The company had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.51 EPS. On average, analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio is currently 97.83%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. The trade was a 19.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. JPMorgan Chase & Co. dropped their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 19th. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JMP Securities reissued a "market outperform" rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Barrington Research dropped their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.